Skip to main content
Veterinary Medicines

Clavucill 400 mg + 100 mg 400 mg - 100 mg Tablet

Authorised
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
  • Amoxicillin trihydrate

Product identification

Medicine name:
Clavucill 400mg/100mg Tabletten für Hunde
Clavucill 400 mg + 100 mg 400 mg - 100 mg Tablet
Active substance:
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
    250.20
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    459.10
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Clavucill 400 mg + 100 mg 400 mg - 100 mg tabl. 100
  • Clavucill 400 mg + 100 mg 400 mg - 100 mg tabl. 10

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • VMD N.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401560.02.00
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0024/003
Concerned member states:
  • Denmark
  • France
  • Germany
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
Generic of:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."